Investor Relations

Investor Relations

At Questcor, we are a biopharmaceutical company whose products help patients with serious, difficult-to-treat medical conditions. Our efforts are currently focused on the fields of neurology and nephrology, areas of medicine which have significant unmet medical needs.

 

Recent Releases

Jan 16, 2012
Questcor Pharmaceuticals Responds to Questions From Investor Blog

Jan 11, 2012
Questcor Pharmaceuticals Issues Statement

Jan 6, 2012
Questcor Pharmaceuticals Reports Strong Finish to 2011

View all releases »

Events & Presentations

Jan 12, 2012 at 10:00 AM PT
Questcor Pharmaceuticals Presents at the 30th Annual J.P. Morgan Healthcare Conference

Dec 13, 2011 at 2:45 PM ET
Questcor Presents at the Oppenheimer Healthcare Conference

View all events & presentations »

Investor Presentation

Stock Chart
Stock price graph
3 Mo.   6 Mo.   1 Yr.
Stock Quote
Questcor Pharmaceuticals, Inc.
Price: 36.48
Change: + 0.49
Day High: 38.34
Day Low: 35.71
Volume: 3,383,700
Delayed at least 20 minutes.
Provided by eSignal.

 

Transfer Agent

Computershare Trust Co., Inc.
Phone 303-262-0600

Corporate Counsel

Stradling Yocca Carlson & Rauth
Newport Beach, CA

Independent Accountants

BDO USA, LLP

Investor Relations Contacts

Doug Sherk, EVC Group, 415-896-6820
or
Tracy Megee, (714) 786-4205